About

Saurabh Saha, M.D., Ph.D., served as Chief Executive Officer of Centessa Pharmaceuticals plc from January 2021 to January 2026 and has advised Centessa since January 2026. He brings over 20 years of experience in health and life sciences.

Before Centessa he was Senior Vice President of R&D and Global Head of Translational Medicine at Bristol Myers Squibb from 2017 to January 2021, and earlier a venture partner at Atlas Venture and President and CEO of Delinia.

Roles

Clarivate Plc
Director · Current role
2023–present
Centessa Pharmaceuticals plc
Chief Executive Officer
January 2021 - January 2026
Bristol Myers Squibb
SVP, R&D and Global Head of Translational Medicine
2017 - January 2021
Atlas Venture Life Science Advisors, LLC
Venture Partner
2015 - 2017
Delinia
President and Chief Executive Officer
—

External Roles

Centessa Pharmaceuticals plc
Director
—
Harvard Medical School
Associate Member and Global Clinical Scholar
—

Director Compensation

FY 2025
Fees Earned or Paid in Cash
$85,000
Stock Awards (RSUs)
$165,000

Also at Clarivate Plc

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.